Phase II Study of AVAC (TM) for the Treatment of Atopic Dermatitis in Childre

Phase 2

Completed

• Conditions: Childhood eczema; Skin - Dermatological conditions

• Registration Number: ACTRN12605000237684
• Lead Sponsor: Genesis Research & Development Corporation Ltd

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2005-08-26
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

Diagnosis of moderate-to-severe atopic dermatitis (AD). Severity defined according to Rajka and Langeland criteria; atopic dermatitis defined according to UK Atopic Dermatitis Working Party criteria.

Exclusion Criteria

No exclusion criteria

Study & Design

• Study Type: Interventional
• Study Design: Not specified